| Cesario Family Dental Center | |
|
28800 Nys Rte 3 Black River NY 13612-2140 | |
| (315) 773-4204 | |
| (315) 773-3126 |
| Full Name | Cesario Family Dental Center |
|---|---|
| Speciality | Dentist |
| Location | 28800 Nys Rte 3, Black River, New York |
| Authorized Official Name and Position | Jolie M Cesario (PRACTICE MANAGER) |
| Authorized Official Contact | 3157734204 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Cesario Family Dental Center 28800 Nys Rte 3 Black River NY 13612-2140 Ph: (315) 773-4204 | Cesario Family Dental Center 28800 Nys Rte 3 Black River NY 13612-2140 Ph: (315) 773-4204 |
| NPI Number | 1215264841 |
|---|---|
| Provider Enumeration Date | 11/03/2009 |
| Last Update Date | 11/03/2009 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215264841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 40430 (New York) | Primary |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.
Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.
Tuberculosis care and control has improved dramatically over the last two decades, but numbers of cases and deaths are still high and multidrug resistant-TB is an under-reported and ever-increasing problem, suggest findings from the World Health Organization Global TB Report 2012.
UCLA, renowned for its leadership in research and treatment for individuals with autism, is launching a first-of-its-kind collaborative research effort to address the health, family and social needs of adolescents and young adults with autism, a group typically overlooked by health care and social services systems.
› Verified 1 days ago